Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosis.

por Clara de Andrés, Roseta Teijeiro, Bárbara Alonso, Francisco Sánchez-Madrid, M Luisa Martínez, Juan Guzmán de Villoria, Eduardo Fernández-Cruz, Silvia Sánchez-Ramón
Publicado 2012